IVA

Inventiva S.A.

Price Chart

No historical data available

Latest Quote

$4.68

-0.03 (-0.53%)

Current Price

Previous Close	$4.71
Open	$4.64
Day High	$4.72
Day Low	$4.53
Volume	1,004,219

Fetched: 2026-09-01T01:37:46

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	236.22M
Total Debt	$268.20M
Cash Equivalents	$115.97M
Revenue	$7.85M
Net Income	$-411.36M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$1.11B
EPS (TTM)	$-2.21
Exchange	NGM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Inventiva S.A.

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.

📰 Latest News

No news articles available at the moment. Check back later for updates on IVA.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$5,235,927	$10,742,818	$20,412,288	$14,224,481
Operating Revenue	$5,235,927	$10,742,818	$20,412,288	$14,224,481
Expenses
Interest Expense	$39,201,124	$14,223,313	$6,047,653	$825,742
Total Expenses	$160,436,826	$120,517,411	$140,320,029	$80,630,700
Other Income Expense	$-222,555,494	$-92,084,800	$-3,410,418	$3,418,594
Net Non Operating Interest Income Expense	$-35,830,416	$-12,928,055	$-4,943,939	$-425,134
Total Other Finance Cost	$68,909	$39,710	$53,726	$54,894
Interest Expense Non Operating	$39,201,124	$14,223,313	$6,047,653	$825,742
Operating Expense	$160,436,826	$120,517,411	$140,320,029	$80,630,700
Other Operating Expenses	$-4,463,911	$-6,407,382	$-6,640,972	$-8,092,736
Selling And Marketing Expense	$5,654,053	$1,969,166	$2,049,755	$2,762,205
General And Administrative Expense	$57,289,189	$18,001,636	$16,178,464	$15,079,422
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-413,616,008	$-215,150,682	$-128,972,212	$-63,389,400
Net Interest Income	$-35,830,416	$-12,928,055	$-4,943,939	$-425,134
Interest Income	$3,439,617	$1,334,969	$1,157,440	$455,501
Normalized Income	$-247,005,975	$-146,361,258	$-128,179,465	$-66,805,943
Net Income From Continuing And Discontinued Operation	$-413,616,008	$-215,150,682	$-128,972,212	$-63,389,400
Total Operating Income As Reported	$-164,696,345	$-113,943,012	$-119,959,131	$-66,701,710
Net Income Common Stockholders	$-413,616,008	$-215,150,682	$-128,972,212	$-63,389,400
Net Income	$-413,616,008	$-215,150,682	$-128,972,212	$-63,389,400
Net Income Including Noncontrolling Interests	$-413,612,504	$-215,153,018	$-128,971,044	$-63,389,400
Net Income Continuous Operations	$-413,612,504	$-215,153,018	$-128,971,044	$-63,389,400
Pretax Income	$-413,586,810	$-214,787,449	$-128,262,098	$-63,412,759
Special Income Charges	$-9,494,278	$-4,168,419	$-51,390	$-151,834
Earnings From Equity Interest	$-408,783	$-365,569	$-2,353,422	$0
Interest Income Non Operating	$3,439,617	$1,334,969	$1,157,440	$455,501
Operating Income	$-155,200,899	$-109,774,594	$-119,907,741	$-66,406,218
Depreciation Amortization Depletion Income Statement	$295,492	$810,558	$244,102	$256,949
Depreciation And Amortization In Income Statement	$295,492	$810,558	$244,102	$256,949
Per Share
Diluted EPS	$-2.22	$-3.60	$-2.84	$-1.53
Basic EPS	$-2.22	$-3.60	$-2.84	$-1.53
Other
Tax Effect Of Unusual Items	$-55,536,678	$-22,929,808	$-264,249	$2,051
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-148,474,666	$-102,773,892	$-118,121,943	$-64,022,429
Total Unusual Items	$-222,146,711	$-91,719,231	$-1,056,996	$3,418,594
Total Unusual Items Excluding Goodwill	$-222,146,711	$-91,719,231	$-1,056,996	$3,418,594
Reconciled Depreciation	$3,764,308	$6,071,012	$3,035,506	$1,983,182
EBITDA (Bullshit earnings)	$-370,621,378	$-194,493,124	$-119,178,939	$-60,603,835
EBIT	$-374,385,685	$-200,564,135	$-122,214,445	$-62,587,017
Diluted Average Shares	$217,692,636	$69,818,624	$52,968,702	$48,411,277
Basic Average Shares	$217,692,636	$69,818,624	$52,968,702	$48,411,277
Diluted NI Availto Com Stockholders	$-413,616,008	$-215,150,682	$-128,972,212	$-63,389,400
Tax Provision	$25,695	$365,569	$708,947	$-23,359
Gain On Sale Of Ppe	$332,866	$175,193	$0	$-10,512
Restructuring And Mergern Acquisition	$9,827,144	$4,343,612	$51,390	$141,322
Gain On Sale Of Security	$-212,652,433	$-87,550,812	$-1,005,606	$3,570,428
Research And Development	$101,662,002	$106,143,432	$128,488,680	$70,624,859
Selling General And Administration	$62,943,242	$19,970,803	$18,228,219	$17,841,627
Other Gand A	$12,704,976	$10,947,209	$10,377,249	$10,193,881
Insurance And Claims	$1,809,157	$0	$0	-
Salaries And Wages	$42,775,056	$7,054,427	$5,801,215	$4,885,541
Write Off	-	$434,478	$0	$0
Impairment Of Capital Assets	-	$2,087,129	$0	$0
Other Taxes	-	-	$0	$0
Provision For Doubtful Accounts	-	-	$0	$0

Fetched: 2026-08-19

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$-33,526,048	$-124,613,417	$-38,043,684	$52,450,366
Total Assets	$291,416,747	$138,947,686	$81,243,874	$135,487,046
Total Non Current Assets	$5,891,147	$8,708,246	$24,963,795	$11,238,029
Non Current Prepaid Assets	$1,357,160	$1,222,845	$11,743,752	$1,872,226
Non Current Deferred Assets	$223,079	$253,445	$262,789	$0
Non Current Deferred Taxes Assets	$223,079	$253,445	$262,789	$0
Goodwill And Other Intangible Assets	$213,735	$56,062	$633,030	$663,396
Other Intangible Assets	$213,735	$56,062	$633,030	$663,396
Current Assets	$285,527,935	$130,239,440	$56,282,415	$124,251,352
Other Current Assets	$614,342	$407,615	$491,708	$329,362
Prepaid Assets	$4,615,744	$2,852,138	$5,437,982	$10,045,551
Inventory	$0	$0	$487,036	$435,646
Receivables	$10,652,886	$14,198,786	$18,345,014	$10,912,171
Other Receivables	$1,957,487	$1,903,761	$1,730,904	$325,858
Taxes Receivable	$6,340,809	$11,674,843	$12,167,719	$10,586,312
Accounts Receivable	$2,354,590	$620,182	$4,446,391	$0
Cash Cash Equivalents And Short Term Investments	$269,644,963	$112,780,901	$31,520,675	$102,528,622
Cash And Cash Equivalents	$115,991,599	$112,780,901	$31,438,918	$101,304,609
Cash Equivalents	$96,505,497	$82,521,613	$20,944,874	$19,619,249
Cash Financial	$19,486,103	$30,259,287	$10,494,044	$81,685,360
Investmentin Financial Assets	-	-	$10,511,564	$817,566
Non Current Accounts Receivable	-	-	-	$75,917
Hedging Assets Current	-	-	-	$0
Other Non Current Assets	-	-	-	-
Debt
Total Debt	$69,912,409	$63,453,637	$43,785,334	$40,311,846
Long Term Debt And Capital Lease Obligation	$32,178,232	$56,600,098	$37,585,847	$33,478,162
Long Term Debt	$31,319,787	$54,106,521	$32,602,198	$29,702,175
Current Debt And Capital Lease Obligation	$37,734,177	$6,853,539	$6,199,487	$6,833,684
Current Debt	$35,356,228	$3,910,302	$3,515,534	$5,342,210
Other Current Borrowings	$35,356,228	$3,910,302	$3,515,534	$5,342,210
Net Debt	-	-	$4,678,814	-
Liabilities
Total Liabilities Net Minority Interest	$324,729,059	$263,505,042	$118,654,529	$82,373,283
Total Non Current Liabilities Net Minority Interest	$234,355,308	$122,497,089	$60,072,417	$46,516,004
Other Non Current Liabilities	$61,712,221	$35,315,350	$8,594,955	$-2,336
Derivative Product Liabilities	$139,435,890	$28,398,741	$11,989,022	$11,534,689
Non Current Deferred Liabilities	$147,162	$124,971	$81,757	$64,237
Current Liabilities	$90,373,751	$141,007,953	$58,582,111	$35,857,279
Other Current Liabilities	$1,168	$85,728,808	-	$-1,168
Current Deferred Liabilities	$0	$0	$7,008	$7,008
Payables And Accrued Expenses	$51,387,530	$48,425,605	$52,375,617	$29,017,755
Payables	$38,844,899	$46,392,202	$50,576,972	$27,452,700
Other Payable	$6,391,031	$3,427,938	$2,209,764	$2,193,413
Total Tax Payable	$2,067,274	$4,583,042	$4,359,963	$2,648,914
Accounts Payable	$30,386,594	$38,381,222	$44,007,245	$22,610,373
Current Deferred Taxes Liabilities	-	-	$0	$0
Equity
Common Stock Equity	$-33,312,313	$-124,557,356	$-37,410,654	$53,113,762
Total Equity Gross Minority Interest	$-33,312,313	$-124,557,356	$-37,410,654	$53,113,762
Stockholders Equity	$-33,312,313	$-124,557,356	$-37,410,654	$53,113,762
Gains Losses Not Affecting Retained Earnings	$-238,899,808	$-201,531,199	$-144,811,971	$-87,078,960
Other Equity Adjustments	$-239,642,625	$-202,231,970	$-145,508,070	$-86,762,445
Retained Earnings	$-413,616,008	$-215,150,682	$-128,972,212	$-63,389,400
Long Term Equity Investment	$615,510	$1,330,297	$1,664,331	$0
Other
Treasury Shares Number	$69,553	$140,764	$123,937	-
Ordinary Shares Number	$225,621,866	$111,729,033	$60,868,735	$49,210,666
Share Issued	$225,691,418	$111,869,797	$60,992,672	$49,210,666
Tangible Book Value	$-33,526,048	$-124,613,417	$-38,043,684	$52,450,366
Invested Capital	$33,363,703	$-66,540,533	$-1,292,922	$88,158,147
Working Capital	$195,154,184	$-10,768,513	$-2,299,697	$88,394,073
Capital Lease Obligations	$3,236,394	$5,436,814	$7,667,602	$5,267,461
Total Capitalization	$-1,992,525	$-70,450,834	$-4,808,456	$82,815,937
Foreign Currency Translation Adjustments	$742,817	$700,771	$696,099	$-316,515
Additional Paid In Capital	$616,947,021	$291,006,796	$235,765,026	$203,090,415
Capital Stock	$2,256,482	$1,117,730	$608,503	$491,708
Common Stock	$2,256,482	$1,117,730	$608,503	$491,708
Employee Benefits	$881,803	$2,057,931	$1,820,836	$1,441,252
Non Current Pension And Other Postretirement Benefit Plans	$881,803	$2,057,931	$1,820,836	$1,441,252
Non Current Deferred Revenue	$147,162	$124,971	$81,757	$64,237
Long Term Capital Lease Obligation	$858,444	$2,493,576	$4,983,649	$3,775,987
Current Deferred Revenue	$0	$0	$7,008	$7,008
Current Capital Lease Obligation	$2,377,949	$2,943,238	$2,683,953	$1,491,474
Current Provisions	$1,250,876	-	-	-
Current Accrued Expenses	$12,542,631	$2,033,404	$1,798,645	$1,565,055
Investments And Advances	$615,510	$1,330,297	$1,664,331	$0
Net PPE	$3,481,663	$5,845,597	$10,659,893	$8,626,490
Accumulated Depreciation	$-19,808,457	$-17,744,687	$-12,512,264	$-9,992,993
Gross PPE	$23,290,121	$23,590,284	$23,172,158	$18,619,483
Construction In Progress	$0	$23,359	$134,314	$75,917
Other Properties	$13,458,305	$12,516,936	$12,238,964	$7,916,375
Machinery Furniture Equipment	$5,579,304	$6,796,310	$6,545,200	$6,373,511
Buildings And Improvements	$4,051,624	$4,052,792	$4,052,792	$4,052,792
Land And Improvements	$200,888	$200,888	$200,888	$200,888
Properties	$0	$0	$0	$0
Other Short Term Investments	$153,653,363	$0	$81,757	$1,224,013
Available For Sale Securities	-	-	$10,511,564	$817,566
Other Inventories	-	-	$487,036	$435,646

Fetched: 2026-08-19

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-122,787,909	$-100,748,664	$-95,951,888	$-53,128,946
Operating Activities
Operating Cash Flow	$-122,499,425	$-100,359,736	$-95,321,194	$-52,473,725
Cash Flow From Continuing Operating Activities	$-122,501,761	$-100,358,569	$-95,321,194	$-52,472,557
Operating Gains Losses	$2,027,564	$-604,999	$2,700,304	$400,607
Investing Activities
Capital Expenditure	$-288,484	$-388,928	$-630,694	$-655,221
Investing Cash Flow	$-155,554,788	$10,213,736	$-9,029,433	$10,357,394
Cash Flow From Continuing Investing Activities	$-155,553,621	$10,213,736	$-9,029,433	$10,356,226
Net Other Investing Changes	$-1,168	-	-	$1,168
Financing Activities
Issuance Of Capital Stock	$241,113,076	$66,968,003	$35,726,468	$10,309,508
Financing Cash Flow	$281,810,346	$170,044,395	$33,965,198	$43,527,217
Cash Flow From Continuing Financing Activities	$281,809,178	$170,044,395	$33,965,198	$43,527,217
Net Other Financing Charges	$-20,010,513	$11,791,638	$3,023,826	$35,282,647
Cash Dividends Paid	$0	$0	$0	-
Net Common Stock Issuance	$241,113,076	$66,968,003	$35,726,468	$10,309,508
Common Stock Issuance	$241,113,076	$66,968,003	$35,726,468	$10,309,508
Other
Repayment Of Debt	$-6,984,350	$-5,830,414	$-4,785,097	$-2,064,938
Issuance Of Debt	$0	$29,100,680	$0	$35,282,647
End Cash Position	$115,991,599	$112,782,069	$31,438,918	$101,303,441
Beginning Cash Position	$112,782,069	$31,438,918	$101,303,441	$101,089,706
Effect Of Exchange Rate Changes	$-546,601	$1,444,756	$519,738	$-1,197,150
Changes In Cash	$3,756,132	$79,898,394	$-70,384,261	$1,410,885
Interest Paid Cff	$-289,652	$0	$0	-
Proceeds From Stock Option Exercised	$67,981,785	$68,014,488	$0	$0
Net Issuance Payments Of Debt	$-6,984,350	$23,270,266	$-4,785,097	$33,217,709
Net Long Term Debt Issuance	$-6,984,350	$23,270,266	$-4,785,097	$33,217,709
Long Term Debt Payments	$-6,984,350	$-5,830,414	$-4,785,097	$-2,064,938
Long Term Debt Issuance	$0	$29,100,680	$0	$35,282,647
Net Investment Purchase And Sale	$-155,265,137	$10,602,664	$-8,551,741	$10,963,561
Purchase Of Investment	$-155,265,137	-	$-9,693,997	$-1,168
Net PPE Purchase And Sale	$-288,484	$-388,928	$-477,692	$-607,335
Sale Of PPE	$0	$0	$153,002	$47,886
Purchase Of PPE	$-288,484	$-388,928	$-630,694	$-655,221
Taxes Refund Paid	$5,740,482	$6,228,685	$6,096,707	$4,149,732
Change In Working Capital	$2,062,602	$1,960,991	$20,213,737	$6,672,507
Change In Other Working Capital	$-1,915,440	$2,095,305	$3,725,765	$-1,967,998
Change In Payables And Accrued Expense	$2,985,284	$-3,898,622	$23,361,366	$4,128,709
Change In Payable	$2,985,284	$-3,898,622	$23,361,366	$4,128,709
Change In Inventory	$0	$487,036	$-51,390	$22,191
Change In Receivables	$992,759	$3,277,272	$-6,822,005	$4,489,606
Other Non Cash Items	$248,940,687	$102,560,157	$2,506,424	$1,263,724
Stock Based Compensation	$31,264,894	$4,181,266	$4,635,600	$2,590,516
Deferred Tax	$-2,683,953	$-5,606,167	$-5,537,258	$-6,144,593
Deferred Income Tax	$-2,683,953	$-5,606,167	$-5,537,258	$-6,144,593
Depreciation Amortization Depletion	$3,764,308	$6,071,012	$3,035,506	$1,983,182
Depreciation And Amortization	$3,764,308	$6,071,012	$3,035,506	$1,983,182
Depreciation	$3,764,308	$6,071,012	$3,035,506	$1,983,182
Earnings Losses From Equity Investments	$408,783	$177,529	$2,353,422	$0
Net Foreign Currency Exchange Gain Loss	$1,590,750	$-1,315,113	$346,882	$400,607
Gain Loss On Sale Of PPE	$28,031	$532,586	$0	$0
Net Income From Continuing Operations	$-413,616,008	$-215,150,682	$-128,972,212	$-63,389,400
Sale Of Investment	-	$10,602,664	$1,142,257	$10,964,729

Fetched: 2026-08-19